These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30514676)

  • 1. [Expression of secreted frizzled-related protein 4 in DNA mismatch repair-deficient and mismatch repair-proficient colorectal cancers].
    Chen K; Liang H; Peng J; Zheng Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1300-1305. PubMed ID: 30514676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer.
    Ma J; Zhang Y; Shen H; Kapesa L; Liu W; Zeng M; Zeng S
    Tumour Biol; 2015 Dec; 36(12):9599-609. PubMed ID: 26142736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the relationship of DNA mismatch repair with clinicopathologic features and prognosis of colon cancer].
    Qin Q; Ying J; Lyu N; Guo L; Zhi W; Zhou A; Wang J
    Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):591-6. PubMed ID: 26714599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intertumoral Heterogeneity of CD3
    Yoon HH; Shi Q; Heying EN; Muranyi A; Bredno J; Ough F; Djalilvand A; Clements J; Bowermaster R; Liu WW; Barnes M; Alberts SR; Shanmugam K; Sinicrope FA
    Clin Cancer Res; 2019 Jan; 25(1):125-133. PubMed ID: 30301825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
    Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
    Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between mismatch repair proteins status and clinicopathological characteristics in sporadic colorectal cancer patients].
    Xiao ZT; Zhang RX; Zhao Y; Peng JH; Lu SX; Zhang HZ; Ding PR; Wu XJ; Lu ZH; Li LR; Wan DS; Pan ZZ; Chen G
    Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(16):1248-1251. PubMed ID: 28441855
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
    Williams DS; Mouradov D; Jorissen RN; Newman MR; Amini E; Nickless DK; Teague JA; Fang CG; Palmieri M; Parsons MJ; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Faragher I; Jones IT; Gibbs P; Sieber OM
    Gut; 2019 Mar; 68(3):465-474. PubMed ID: 29382774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
    Li P; Xiao Z; Braciak TA; Ou Q; Chen G; Oduncu FS
    PLoS One; 2017; 12(3):e0172799. PubMed ID: 28253296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different surgical outcome and follow-up status between dMMR and pMMR colorectal cancer patients who fulfilled with Amsterdam-II criteria.
    Sun CY; Chiang JM; Chen TC; Hung HY; You JF
    World J Surg Oncol; 2020 Aug; 18(1):195. PubMed ID: 32767993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LDH-A negatively regulates dMMR in colorectal cancer.
    Zhang Y; Li J; Wang B; Chen T; Chen Y; Ma W
    Cancer Sci; 2021 Aug; 112(8):3050-3063. PubMed ID: 34110068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancer.
    Rico SD; Höflmayer D; Büscheck F; Dum D; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Möller-Koop C; Perez D; Izbicki JR; Neipp M; Mofid H; Lárusson H; Daniels T; Isbert C; Coerper S; Ditterich D; Rupprecht H; Goetz A; Fraune C; Möller K; Menz A; Bernreuther C; Clauditz TS; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Lebok P; Burandt E; Krech T; Marx AH
    Med Mol Morphol; 2021 Jun; 54(2):156-165. PubMed ID: 33373033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers.
    Hale VL; Jeraldo P; Chen J; Mundy M; Yao J; Priya S; Keeney G; Lyke K; Ridlon J; White BA; French AJ; Thibodeau SN; Diener C; Resendis-Antonio O; Gransee J; Dutta T; Petterson XM; Sung J; Blekhman R; Boardman L; Larson D; Nelson H; Chia N
    Genome Med; 2018 Oct; 10(1):78. PubMed ID: 30376889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient mismatch repair as a prognostic marker in stage II colon cancer patients.
    Gkekas I; Novotny J; Fabian P; Nemecek R; Palmqvist R; Strigård K; Pecen L; Svoboda T; Gurlich R; Gunnarsson U
    Eur J Surg Oncol; 2019 Oct; 45(10):1854-1861. PubMed ID: 31186203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saffron and Its Major Ingredients' Effect on Colon Cancer Cells with Mismatch Repair Deficiency and Microsatellite Instability.
    Amin A; Farrukh A; Murali C; Soleimani A; Praz F; Graziani G; Brim H; Ashktorab H
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34202689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of lysine-specific demethylase 6A (KDM6A) and mismatch repair (MMR) status is a potential prognostic factor in colorectal cancer.
    Chen X; Yang Z; Feng J; Duan T; Pan T; Yan L; Jin T; Xiang Y; Zhang M; Chen P; Wang W; Zhang R; Chen B; Zhao L; Xie T; Sui X
    Cancer Med; 2021 Jan; 10(1):317-324. PubMed ID: 33174323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA ENST00000455974 plays an oncogenic role through up-regulating JAG2 in human DNA mismatch repair-proficient colon cancer.
    Lao Y; Li Q; Li N; Liu H; Liu K; Jiang G; Wei N; Wang C; Wang Y; Wu J
    Biochem Biophys Res Commun; 2019 Jan; 508(2):339-347. PubMed ID: 30473216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics and Outcomes of Treatment in Patients with Stage IV Colorectal Cancer with Mismatch Repair Deficiency].
    Ishibashi K; Chika N; Suzuki O; Ito T; Amano K; Kumamoto K; Fukuchi M; Kumagai Y; Mochiki E; Ishida H
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1711-1714. PubMed ID: 28133107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.
    Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J
    PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlations between DNA mismatch repair (MMR) and prognosis and prediction of treatment efficacy in stage II/II colon cancer].
    Qin Q; Ying J; Lyu N; Guo L; Zhi W; Zhou A; Wang J
    Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):844-8. PubMed ID: 25620482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Budding
    Karlberg M; Stenstedt K; Hallström M; Ragnhammar P; Lenander C; Edler D
    Anticancer Res; 2018 Aug; 38(8):4713-4721. PubMed ID: 30061240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.